4m49

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
{{STRUCTURE_4m49| PDB=4m49 | SCENE= }}
{{STRUCTURE_4m49| PDB=4m49 | SCENE= }}
===Lactate Dehydrogenase A in complex with a substituted pyrazine inhibitor compound 18===
===Lactate Dehydrogenase A in complex with a substituted pyrazine inhibitor compound 18===
 +
{{ABSTRACT_PUBMED_24012183}}
==Disease==
==Disease==
Line 9: Line 10:
==Reference==
==Reference==
-
<references group="xtra"/><references/>
+
<ref group="xtra">PMID:024012183</ref><references group="xtra"/><references/>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: L-lactate dehydrogenase]]
[[Category: L-lactate dehydrogenase]]

Revision as of 05:59, 2 October 2013

Template:STRUCTURE 4m49

Contents

Lactate Dehydrogenase A in complex with a substituted pyrazine inhibitor compound 18

Template:ABSTRACT PUBMED 24012183

Disease

[LDHA_HUMAN] Defects in LDHA are the cause of glycogen storage disease type 11 (GSD11) [MIM:612933]. A metabolic disorder that results in exertional myoglobinuria, pain, cramps and easy fatigue.[1]

About this Structure

4m49 is a 4 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

  • Fauber BP, Dragovich PS, Chen J, Corson LB, Ding CZ, Eigenbrot C, Giannetti AM, Hunsaker T, Labadie S, Liu Y, Liu Y, Malek S, Peterson D, Pitts K, Sideris S, Ultsch M, Vanderporten E, Wang J, Wei B, Yen I, Yue Q. Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase. Bioorg Med Chem Lett. 2013 Oct 15;23(20):5533-9. doi: 10.1016/j.bmcl.2013.08.060., Epub 2013 Aug 22. PMID:24012183 doi:10.1016/j.bmcl.2013.08.060
  1. Maekawa M, Sudo K, Kanno T, Li SS. Molecular characterization of genetic mutation in human lactate dehydrogenase-A (M) deficiency. Biochem Biophys Res Commun. 1990 Apr 30;168(2):677-82. PMID:2334430

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools